65 demonstrated a moderately significant relationship between baseline HBeAg levels and subsequent HBeAg seroconversion in patients receiving PegIFN.
← all excerpts
Combination Therapy for Chronic Hepatitis B: Current Updates and Perspectives.
1
—
—
65 demonstrated a moderately significant relationship between baseline HBeAg levels and subsequent HBeAg seroconversion in patients receiving PegIFN.